Lv2
106 积分 2022-01-21 加入
Current and Future Implications of Weight Loss Drugs on Liver Disease
5个月前
已关闭
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
5个月前
已完结
Fenofibrate promotes erucic acid metabolism by peroxisome enzyme EHHADH activation alleviating high-fat diet–induced steatotic liver disease
6个月前
已完结
Metabolome-wide association identifies ferredoxin-1 (FDX1) as a determinant of cholesterol metabolism and cardiovascular risk in Asian populations
1年前
已完结
皖公网安备34019202002308
